[1]
E. Nomozov and N. Srojidinova, Trans., “Application of GLP-1 Receptor Agonists in Cardiorenometabolic Syndrome”, Je, vol. 3, no. 1, pp. 101–108, Mar. 2026, doi: 10.70626/cardiouz-2026-3-00082.